Detection and characterization of VIM-52, a new variant of VIM-1 from Klebsiella pneumoniae clinical isolate - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2021

Detection and characterization of VIM-52, a new variant of VIM-1 from Klebsiella pneumoniae clinical isolate

Eddy Elisée
Bogdan Iorga

Résumé

Over the last two decades, antimicrobial resistance has become a global health problem. In Gram-negative bacteria, metallo-β-lactamases (MBLs), which inactivate virtually all β-lactams, increasingly contribute to this phenomenon. The aim of this study is to characterize VIM-52, a His224Arg variant of VIM-1, identified in a Klebsiella pneumoniae clinical isolate. VIM-52 conferred lower MICs to cefepime and ceftazidime as compared to VIM-1. These results were confirmed by steady state kinetic measurements, where VIM-52 yielded a lower activity towards ceftazidime and cefepime but not against carbapenems. Residue 224 is part of the L10 loop (residues 221-241), which borders the active site. As Arg 224 and Ser 228 are both playing an important and interrelated role in enzymatic activity, stability and substrate specificity for the MBLs, targeted mutagenesis at both positions were performed and further confirmed their crucial role for substrate specificity.
Fichier principal
Vignette du fichier
AAC02660-20R2-Merged_PDF.pdf (5.55 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03336206 , version 1 (07-09-2021)

Identifiants

Citer

Marie de Barsy, Paola Sandra Mercuri, Saoussen Oueslati, Eddy Elisée, Te-Din Huang, et al.. Detection and characterization of VIM-52, a new variant of VIM-1 from Klebsiella pneumoniae clinical isolate. Antimicrobial Agents and Chemotherapy, 2021, 65 (11), pp.e02660-20. ⟨10.1128/aac.02660-20⟩. ⟨hal-03336206⟩
81 Consultations
26 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More